News on haematological malignancies
ASH 2022: CAR-T-cell shows promise in patients with lymphoma of the brain and spinal cord in early trial
A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of…
Browsing: Haematology
ASH 2022: MajesTEC-2 trial of teclistamab-cqyv in combination with daratumumab and hyaluronidase-fihj and lenalidomide shows clinical activity in RRMM
According to the results of the phase 1b MajesTEC-2 study, the immune-based triplet therapy regimen of teclistamab-cqyv, a…
ASH 2022: Talquetamab generates high response rate in patients with hard-to-treat multiple myeloma
In an early-phase trial, nearly three-quarters of patients who received talquetamab, a first-in-class experimental immunotherapy…
Researchers find treatment options for patients whose blood cancer relapses after CAR-T
Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers in the USA have identified…
There’s a better way to detect high-risk medications in older adults with cancer
A new study in the August 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests…
New immunotherapy for blood cancers
Researchers at QIMR Berghofer and Peter MacCallum Cancer Centre have discovered a new vital clue…
Study underscores impact of fatigue in blood cancer
People with a rare type of blood cancer often experience fatigue that is debilitating, distressing…
New metabolic profile in patients with acute myeloid leukaemia
An article published in the journal Nature Communications describes a specific metabolic adaptation in some patients with…
Adults with blood cancers respond to booster, not initial dose of COVID-19 vaccine
Most patients in the study mounted immune responses after a booster dose, and no patient…
‘Goldilocks’ treatment window could lead to cancer therapy without harmful side-effects
Researchers have developed a way to potentially reduce the toxic side-effects of a type of…